You are here

Drug Safety Issues

Researchers suggest FDA regulation of yohimbe and energy products
Seeking to limit spread of infections, FDA clears improved device and manual
Praxbind reversed anticoagulant’s effect immediately in emergency settings
FDA requested the withdrawal because of a spike in abuse
Those most likely to abuse opioids are most likely to receive them
FDA’s post-marketing surveillance system is broken, expert says
Bacteria in water systems can cause deadly pneumonia
Finger of suspicion points to Ocrevus, but Tysabri may be the real culprit
Data show medications nearly doubled the chances of leg and foot amputations
CDC recommends retesting for certain children, pregnant women, and nursing mothers
Some health care centers find ways to “game” the system
Treatments should be monitored throughout their life cycles, authors advise